Header cover image

Market Cap


Last Updated

2021/05/07 22:04 UTC

Data Sources

Company Financials

Executive Summary

Enlighta Inc. operates as a healthcare and medical digital, green, and clean technology company. More Details

Snowflake Analysis

Excellent balance sheet and fair value.

Share Price & News

How has Enlighta's share price performed over time and what events caused price changes?

Latest Share Price and Events

Stable Share Price: Insufficient data to determine NLTA's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine NLTA's volatility change over the past year.

Market Performance

7 Day Return




CA Healthcare Services


CA Market

1 Year Return




CA Healthcare Services


CA Market

Return vs Industry: NLTA underperformed the Canadian Healthcare Services industry which returned 97% over the past year.

Return vs Market: NLTA underperformed the Canadian Market which returned 37.1% over the past year.

Shareholder returns

7 Day-7.7%-0.3%1.9%
30 Day-14.3%-3.9%2.2%
90 Day-25.0%-5.1%8.3%
1 Year-40.0%-40.0%101.2%101.2%41.4%36.9%
3 Year-94.1%-94.1%-43.9%-43.9%30.1%17.7%
5 Year-97.7%-97.7%-74.1%-74.1%60.1%36.2%

Long-Term Price Volatility Vs. Market

How volatile is Enlighta's share price compared to the market and industry in the last 5 years?

Simply Wall St News


Is Enlighta undervalued compared to its fair value and its price relative to the market?


Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: NLTA (CA$0.12) is trading below our estimate of fair value (CA$0.87)

Significantly Below Fair Value: NLTA is trading below fair value by more than 20%.

Price To Earnings Ratio

PE vs Industry: NLTA is unprofitable, so we can't compare its PE Ratio to the XN Healthcare Services industry average.

PE vs Market: NLTA is unprofitable, so we can't compare its PE Ratio to the Canadian market.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NLTA's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: NLTA is good value based on its PB Ratio (1.3x) compared to the CA Healthcare Services industry average (8.6x).

Future Growth

How is Enlighta forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Enlighta has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Enlighta performed over the past 5 years?


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: NLTA is currently unprofitable.

Growing Profit Margin: NLTA is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: NLTA is unprofitable, and losses have increased over the past 5 years at a rate of 24.8% per year.

Accelerating Growth: Unable to compare NLTA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NLTA is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (18.1%).

Return on Equity

High ROE: NLTA has a negative Return on Equity (-331.39%), as it is currently unprofitable.

Financial Health

How is Enlighta's financial position?

Financial Position Analysis

Short Term Liabilities: NLTA's short term assets (CA$373.3K) do not cover its short term liabilities (CA$2.0M).

Long Term Liabilities: NLTA has no long term liabilities.

Debt to Equity History and Analysis

Debt Level: NLTA is debt free.

Reducing Debt: NLTA had no debt 5 years ago.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable NLTA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: NLTA is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 19% per year.


What is Enlighta current dividend yield, its reliability and sustainability?

Dividend Yield vs Market

Notable Dividend: Unable to evaluate NLTA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NLTA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NLTA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NLTA's dividend payments have been increasing.

Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NLTA's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.

Next Steps


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Avis Zhu



Ms. Yun Zhu, also known as Avis, serves as Chief Executive Officer and Director at Enlighta Inc. (formerly known as, HooXi Network Inc.) since October 9, 2018. Ms. Zhu serves as Chief Marketing Officer of ...

CEO Compensation Analysis

Compensation vs Market: Insufficient data to establish whether Avis's total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: Insufficient data to compare Avis's compensation with company performance.

Leadership Team

Experienced Management: NLTA's management team is seasoned and experienced (10.9 years average tenure).

Board Members

Experienced Board: NLTA's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Enlighta Inc.'s company bio, employee growth, exchange listings and data sources

Key Information

  • Name: Enlighta Inc.
  • Ticker: NLTA
  • Exchange: TSXV
  • Founded: 2010
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: CA$2.050m
  • Shares outstanding: 17.08m
  • Website:

Number of Employees


  • Enlighta Inc.
  • 30 DeCastro Street
  • Wickhams Cay 1
  • Road Town
  • Tortola
  • British Virgin Islands



Enlighta Inc. operates as a healthcare and medical digital, green, and clean technology company. It offers virtual medical care solutions, including disease prevention, detection, interventional therapy, a...

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/07 22:04
End of Day Share Price2021/05/06 00:00
Annual Earnings2020/06/30

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.